The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 09, 2018
Filed:
Sep. 06, 2013
Applicant:
Emory University, Atlanta, GA (US);
Inventors:
Rama Rao Amara, Decatur, GA (US);
June R. Scott, Atlanta, GA (US);
Bernard Quigley, Atlanta, GA (US);
Venkateswarlu Chamcha, Atlanta, GA (US);
Assignee:
Emory University, Atlanta, GA (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/21 (2006.01); C12N 7/00 (2006.01); A61K 45/06 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/21 (2013.01); A61K 45/06 (2013.01); C12N 7/00 (2013.01); A61K 2039/523 (2013.01); A61K 2039/542 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/55544 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55594 (2013.01); C12N 2740/16034 (2013.01); C12N 2740/16234 (2013.01);
Abstract
This disclosure relates to recombinant bacteria, e.g., expressing heterologous pili containing human immunodeficiency virus (HIV) antigens. In certain embodiments, the recombinant bacteria are administered in combination with other HIV antigens, nucleic acids encoding HIV antigens, recombinant virus encoding HIV antigens, anti-viral agents and/or adjuvants in an effective amount to elicit a mucosal immune response against HIV.